Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression

Area of Science:

• Neuroendocrinology
• Psychiatry
• Genetics

Background:

• Disinhibited hypothalamic-pituitary-adrenocortical (HPA) activity, indicated by abnormal dexamethasone suppression test (DST) responses, occurs in 40-50% of endogenous depression patients.
• The heterogeneity of DST responses in endogenous depression is not well understood.
• Previous research suggested genetic factors might explain this heterogeneity, with varying abnormal DST response frequencies across different subtypes of primary unipolar depression.

Purpose of the Study:

• To investigate the frequency of abnormal DST responses in primary endogenous delusional unipolar depression.
• To examine whether DST response heterogeneity exists within subtypes of depression spectrum disease.

Main Methods:

• Studied 14 patients with primary endogenous delusional unipolar depression.
• Assessed dexamethasone suppression test (DST) responses in all patients.
• Subtyped patients according to Winokur's genetic criteria for depression spectrum disease.

Main Results:

• 79% of the studied patients exhibited abnormal DST responses.
• Abnormal DST responses occurred with similar frequencies across different Winokur subtypes.
• Specifically, 83% of patients with depression spectrum disease showed abnormal DST results, contrasting with a previously reported 4% frequency.

Conclusions:

• Disinhibited HPA activity is prevalent in depression spectrum disease presenting as delusional endogenous depression.
• Results align with a threshold model of HPA activation, potentially influenced by central pain mechanisms.
• Variations in clinical pain dimensions and HPA activation thresholds may explain DST response heterogeneity in endogenous depression.